text_1: TRAP+ osteoclasts regulate mature osteoblast maintenance.
text_2: Thus, pharmacotherapies that increase PDGF-BB secretion from preosteoclasts offer a new therapeutic target for treating osteoporosis by promoting angiogenesis and thus bone formation.